Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, April 16, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
GE Healthcare Life Sciences Launches Xuri™ Technology Family
Wednesday, November 13, 2013
First product introduced - Xuri Cell Expansion System W25 for the clinical manufacture of cellular immunotherapies.

Phenom-World Launches the New Particlemetric Software for Fully Automated Inspection and Analysis of Particles
Tuesday, November 12, 2013
With the introduction of the ParticleMetric software, the visualization and analysis of particles are easier than ever before with the Phenom desktop SEM.

Spinnovation Introduces New Elemental and Trace Metals Analysis
Tuesday, November 05, 2013
New Elemental Analysis for cell culture media and raw materials.

Avoiding Sample Loss During Evaporative Drying
Tuesday, November 05, 2013
Dri-Pure® technology from Genevac offers significant benefits to scientists, especially those working in synthesis and purification.

Protocol for Preparing Top Quality Lyophilised Samples
Tuesday, November 05, 2013
Genevac Develops protocol for improving evaporation and lyophilisation results.

New Method for Microcarrier Cell Culture using TAP’s ambr Micro Bioreactors
Thursday, October 31, 2013
Saves time optimizing process conditions enabling rapid vaccine production.

Seward Introduces Searchable Online Database
Wednesday, October 30, 2013
Unique web Resource Centre contains expanding reference paper guide.

Cobra Biologics Expands Antibody GMP Production Capacity
Tuesday, October 29, 2013
Company installs new 1000L HyClone SUB at the company’s centre of excellence.

Major Food Ingredients Firm Chr. Hansen Installs Fill-It™
Friday, October 25, 2013
To meet increasing demand for its high quality bacterial starter cultures.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 403
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv